skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8847

Comparison of the efficiencies of two TR-FRET methods to detect in vitro natural and synthesized inhibitors of the Raf/MEK/ERK signaling pathway

Original Research

(1520) Views  (1082) Full article downloads

Authors: Fabienne Saab, Sylvain Routier, Jean-Yves Mérour, et al

Published Date June 2010 Volume 2010:1 Pages 81 - 98
DOI: http://dx.doi.org/10.2147/IJHTS.S9157

Fabienne Saab1,2, Sylvain Routier2, Jean-Yves Mérour2, Valérie Bénéteau2, Françoise Schoentgen1,3

1Centre de Biophysique Moléculaire UPR4301 CNRS, affiliated to Orleans University and to INSERM, France; 2Institut de Chimie Organique et Analytique UMR6005 CNRS, Université d’Orléans, France; 3IMPMC UMR 7590 CNRS, Université Pierre et Marie Curie, France

Abstract: Numerous types of cancer operate through the deregulation of the Raf/MEK/ERK pathway. It is therefore of importance to design and synthesize inhibitors of this pathway. Consequently, we have developed several tests to measure in vitro the effect of inhibitors on the activity of the complete cascade Raf-1/MEK/ERK and also on the activities of Raf-1, MEK, and ERK individually. We present here the results obtained with two time-resolved fluorescence resonance energy transfer (TR-FRET) methods by comparison with a classical radioactivity method and experimental data found in literature. The capability of a series of optimized assays to detect different types of inhibitors is evaluated and discussed.

Keywords: Raf/MEK/ERK cascade, inhibitors of Raf-1, MEK, and ERK, PEBP/RKIP, phosphocellulose filter binding assay, time-resolved fluorescence resonance energy transfer








Readers of this article also read:

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Computational characterization of SAR microenvironments in high-throughput screening data
Cell line and drug-dependent effect of ERBB3 on cancer cell proliferation, chemosensitivity, and multidrug actions
A novel cell-based 384-well, label-free assay for discovery of inhibitors of influenza A virus
New developments and emerging trends in high-throughput screening methods for lead compound identification
Perception of risk and benefit in patient-centered communication and care
Steroid response pattern and outcome of pediatric idiopathic nephrotic syndrome: a single-center experience in northwest Iran
The relationship between deliberate self-harm behavior, body dissatisfaction, and suicide in adolescents: current concepts
Zinc oxide nanoparticles as selective killers of proliferating cells
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
  • Testimonials

    "You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio